Citizens & Northern Corp Increases Stake in CVS Health Corporation (NYSE:CVS)

Citizens & Northern Corp boosted its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 65.5% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 27,520 shares of the pharmacy operator's stock after buying an additional 10,887 shares during the quarter. Citizens & Northern Corp's holdings in CVS Health were worth $1,864,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the stock. Dodge & Cox raised its position in shares of CVS Health by 11.2% during the fourth quarter. Dodge & Cox now owns 70,105,899 shares of the pharmacy operator's stock worth $3,147,054,000 after acquiring an additional 7,075,209 shares during the last quarter. Capital World Investors raised its position in shares of CVS Health by 26.6% during the fourth quarter. Capital World Investors now owns 61,039,777 shares of the pharmacy operator's stock worth $2,739,927,000 after acquiring an additional 12,819,148 shares during the last quarter. Geode Capital Management LLC raised its position in shares of CVS Health by 2.6% during the fourth quarter. Geode Capital Management LLC now owns 27,051,540 shares of the pharmacy operator's stock worth $1,211,582,000 after acquiring an additional 689,867 shares during the last quarter. Capital International Investors raised its position in shares of CVS Health by 4.8% during the fourth quarter. Capital International Investors now owns 26,666,401 shares of the pharmacy operator's stock worth $1,196,989,000 after acquiring an additional 1,212,126 shares during the last quarter. Finally, Pzena Investment Management LLC raised its position in shares of CVS Health by 49.3% during the fourth quarter. Pzena Investment Management LLC now owns 19,610,579 shares of the pharmacy operator's stock worth $880,319,000 after acquiring an additional 6,475,271 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. Robert W. Baird raised their price objective on CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 15th. Morgan Stanley reiterated an "overweight" rating on shares of CVS Health in a report on Tuesday, April 15th. Wall Street Zen upgraded CVS Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Wells Fargo & Company reiterated an "overweight" rating and issued a $84.00 target price (up from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Finally, Royal Bank Of Canada lifted their target price on CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a report on Monday, May 5th. Two analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, CVS Health presently has a consensus rating of "Moderate Buy" and an average price target of $74.75.

CVS Health Stock Down 0.2%

Shares of NYSE:CVS traded down $0.15 during mid-day trading on Friday, hitting $66.69. 11,828,346 shares of the company traded hands, compared to its average volume of 10,963,290. The stock has a market cap of $84.36 billion, a P/E ratio of 15.92, a P/E/G ratio of 0.96 and a beta of 0.56. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $72.51. The stock has a 50-day moving average price of $64.92 and a two-hundred day moving average price of $60.40.

CVS Health (NYSE:CVS - Get Free Report) last announced its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.63. The company had revenue of $94.59 billion for the quarter, compared to analysts' expectations of $93.07 billion. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. CVS Health's quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.31 earnings per share. On average, equities research analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.

Insider Activity at CVS Health

In other CVS Health news, Director Guy P. Sansone acquired 1,570 shares of CVS Health stock in a transaction on Thursday, June 5th. The stock was purchased at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the purchase, the director now directly owns 12,007 shares of the company's stock, valued at $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 1.22% of the stock is owned by insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.